Lexatumumab
Product Specifications
CAS Number
845816-02-6
Target
Apoptosis
Related Pathways
Apoptosis
Purity
>95%
Bioactivity
Lexatumumab (GHS-ETR 2) is a human excitatory monoclonal antibody targeting TRAIL receptor 2 that has anticancer activity and induces apoptosis in malignant mesothelioma. Lexatumumab can be used to study malignant pleural mesothelioma (MPM) .
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6185347-01 0.1 mL
RIPK4 (Receptor-Interacting Serine-Threonine Kinase 4, ANKK2, ANKRD3, DIK, MGC129992, MGC129993, PKK, RIP4) (PE)
Ask
View Details 
MBS6185347-02 5x 0.1 mL
RIPK4 (Receptor-Interacting Serine-Threonine Kinase 4, ANKK2, ANKRD3, DIK, MGC129992, MGC129993, PKK, RIP4) (PE)
Ask
View Details 
GTR15300455 1 Vial
Lentiviral human MED25 shRNA (UAS) - Lentiviral human MED25 shRNA (UAS, GFP) (25)
Ask
View Details GTR15150473 1 Vial
Lentiviral human AQP11 shRNA (UAS) - Lentiviral human AQP11 shRNA (UAS) (25)
Ask
View Details